Supplementary Figure 3 from miR-155 Drives Metabolic Reprogramming of ER<sup>+</sup> Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors

Marina Bacci,Elisa Giannoni,Antony Fearns,Ricardo Ribas,Qiong Gao,Maria Letizia Taddei,Gianfranco Pintus,Mitch Dowsett,Clare M. Isacke,Lesley-Ann Martin,Paola Chiarugi,Andrea Morandi

crossref（2023）

引用 0|浏览16

暂无评分

摘要

Supplementary Figure S3. 2-DG and metformin treatment do not cause apoptosis to the ER+ MCF7-LTED cells but impair survival fraction of the ER- ZR75-LTED.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 3 from miR-155 Drives Metabolic Reprogramming of ER&lt;sup&gt;+&lt;/sup&gt; Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors

Supplementary Figure 3 from miR-155 Drives Metabolic Reprogramming of ER<sup>+</sup> Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors